Journal of Formulation Science & Bioavailability

Department of Pharmacy, University of Illinois, Chicago, IL 61820, USA

Publications

• Mini-Review   
  Transcriptional Analysis for Synergistic Drug Identification in AML
  Author(s): Zamari Niazi*
  
  Acute Myeloid Leukemia (AML) is a complex and aggressive form of blood cancer characterized by the rapid growth of abnormal white blood cells in the bone marrow. Despite significant advancements in cancer research and treatment, AML remains a challenging disease to combat. Standard chemotherapy regimens have limited efficacy, and many patients face relapse or resistance to treatment. To address these challenges, researchers are turning to innovative approaches such as transcriptional analysis to identify synergistic drug combinations for more effective AML treatment. Transcriptional analysis, also known as gene expression profiling, offers a comprehensive view of the genetic and molecular landscape of AML cells. By examining the activity of thousands of genes simultaneously, researchers can gain valuable insights into the underlying mechanisms of AML and identi.. Read More»
  DOI: 10.37421/2577-0543.2023.7.163

  Abstract HTML PDF